{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:01:35Z","timestamp":1788303695765,"version":"build-2803163510"},"reference-count":24,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"DOI":"10.1182\/bloodadvances.2023010407","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T12:43:32Z","timestamp":1686919412000},"page":"5210-5214","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-8454","authenticated-orcid":false,"given":"Zachary D.","family":"Crees","sequence":"first","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Rettig","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Bashey","sequence":"additional","affiliation":[{"name":"2Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[{"name":"3Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4335-2554","authenticated-orcid":false,"given":"Samantha","family":"Jaglowski","sequence":"additional","affiliation":[{"name":"4Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-5553","authenticated-orcid":false,"given":"Fei","family":"Wan","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Harding","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Vainstein-Haras","sequence":"additional","affiliation":[{"name":"5BioLineRx Ltd, Modi\u2019in, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Sorani","sequence":"additional","affiliation":[{"name":"5BioLineRx Ltd, Modi\u2019in, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Gliko-Kabir","sequence":"additional","affiliation":[{"name":"5BioLineRx Ltd, Modi\u2019in, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1500-8211","authenticated-orcid":false,"given":"Brenda J.","family":"Grossman","sequence":"additional","affiliation":[{"name":"6Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Westervelt","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"DiPersio","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-0996","authenticated-orcid":false,"given":"Geoffrey L.","family":"Uy","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"7","key":"2023092214344539300_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1702875","article-title":"Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases","volume":"27","author":"Anderlini","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2023092214344539300_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1537-2995.2003.00361.x","article-title":"Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim","volume":"43","author":"Moncada","year":"2003","journal-title":"Transfusion"},{"issue":"9107","key":"2023092214344539300_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle-cell crisis","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"2023092214344539300_bib4","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration","volume":"97","author":"Adler","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2023092214344539300_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/14653240902849788","article-title":"Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?","volume":"11","author":"Fitzhugh","year":"2009","journal-title":"Cytotherapy"},{"issue":"5403","key":"2023092214344539300_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"issue":"2","key":"2023092214344539300_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI15994","article-title":"Disruption of the CXCR4\/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide","volume":"111","author":"L\u00e9vesque","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"2023092214344539300_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0076-6879(09)05203-3","article-title":"CXCR4 and mobilization of hematopoietic precursors","volume":"460","author":"Rettig","year":"2009","journal-title":"Methods Enzymol"},{"issue":"28","key":"2023092214344539300_bib9","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","article-title":"Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin\u2019s lymphoma","volume":"27","author":"DiPersio","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"2023092214344539300_bib10","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"issue":"19","key":"2023092214344539300_bib11","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2016-09-739722","article-title":"Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft","volume":"129","author":"Schroeder","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2023092214344539300_bib12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood-2007-12-130179","article-title":"Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4\/SDF-1 interaction","volume":"112","author":"Devine","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2023092214344539300_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2018027599","article-title":"Plerixafor alone for\u00a0the mobilization and transplantation of HLA-matched sibling\u00a0donor hematopoietic stem cells","volume":"3","author":"Chen","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"2023092214344539300_bib14","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1182\/bloodadvances.2021005149","article-title":"Machine learning\u2013based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors","volume":"6","author":"Xiang","year":"2022","journal-title":"Blood Adv"},{"issue":"9","key":"2023092214344539300_bib15","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1634\/stemcells.2007-0161","article-title":"Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003","volume":"25","author":"Abraham","year":"2007","journal-title":"Stem Cells"},{"issue":"6","key":"2023092214344539300_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/10428194.2021.1872068","article-title":"A\u00a0phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes","volume":"62","author":"Huselton","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2023092214344539300_bib17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cyto.a.23303","article-title":"OMIP-042: 21-color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood","volume":"93","author":"Staser","year":"2018","journal-title":"Cytometry A"},{"issue":"17","key":"2023092214344539300_bib18","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1074\/jbc.M010429200","article-title":"Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor","volume":"276","author":"Gerlach","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"2023092214344539300_bib19","doi-asserted-by":"crossref","first-page":"16036","DOI":"10.1038\/s41598-020-73012-4","article-title":"Microtiter plate-based antibody-competition assay to determine binding affinities and plasma\/blood stability of CXCR4 ligands","volume":"10","author":"Harms","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"2023092214344539300_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-023-02273-z","article-title":"Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial","volume":"29","author":"Crees","year":"2023","journal-title":"Nat Med"},{"issue":"9","key":"2023092214344539300_bib21","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1182\/blood-2005-09-3592","article-title":"AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates","volume":"107","author":"Larochelle","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2023092214344539300_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbmt.2006.12.445","article-title":"Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD\/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor","volume":"13","author":"Hess","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2023092214344539300_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.2022015522","article-title":"Immune landscape after allo-HSCT:\u00a0TIGIT- and CD161-expressing CD4\u00a0T cells are associated with subsequent leukemia relapse","volume":"140","author":"Gournay","year":"2022","journal-title":"Blood"},{"key":"2023092214344539300_bib24","doi-asserted-by":"crossref","first-page":"761448","DOI":"10.3389\/fimmu.2021.761448","article-title":"T\u00a0cell subsets in graft versus host disease and graft versus tumor","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5210\/2080124\/blooda_adv-2023-010407-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5210\/2080124\/blooda_adv-2023-010407-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T10:35:01Z","timestamp":1695378901000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5210\/496392\/Hematopoietic-stem-cell-mobilization-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010407","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]}}}